Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Interpretable Artificial Intelligence across Scales for Next-Generation Cancer Prognostics

Project description

Explainable AI for cancer diagnosis

AI has entered the world of computational pathology, assisting in the analysis of tissue samples. This has the potential to improve cancer prognosis and guide treatment decisions beyond traditional grading systems. However, current methods struggle to provide transparent results and explain the reasoning patterns and which features influence the prediction. The ERC-funded AIS-CaP project aims to improve model explainability by developing new machine learning approaches that integrate global and local image information. The methods will be validated using one of the world’s largest cancer image datasets. They will also be linked to genetic data to uncover new biomarkers. The team will openly share the generated tools to accelerate advances in cancer research.

Objective

Computation pathology has the potential to revolutionize cancer care and research, specifically through improving assessment of patient prognosis and treatment selection by applying advanced machine learning methods to digitized tissue sections, i.e. whole-slide images (WSIs). This will allow us to replace the current state-of-the-art of human-developed cancer grading systems. However, the field is currently hindered by significant knowledge gaps: we do not know how to effectively leverage both global and local information in WSIs, how to identify pan-cancer prognostic features, and how to make machine learning models explainable and interpretable. In this project, I will address these key knowledge gaps by building on the novel stochastic streaming gradient descent developed in my group. Specifically, I will integrate innovative multi-task and cross-task learning algorithms with SSGD. Furthermore, I will leverage the latest advances in self-supervision, self-attention and natural language processing to endow deep neural networks with unprecedented transparency and explainability. Last, the project will validate our developed methodology in the largest dataset of oncological WSIs in the world, and, for the first time, identify links between morphological prognostic features and genetic features. By publicly releasing all developed tools and data, the proposed project will have a scientific multiplier effect for the fields of oncology, computational pathology and machine learning. Specifically, the derived cancer-specific and pan-cancer biomarkers can be leveraged in clinical care and cancer research, the enhanced SSGD method for other tasks in computational pathology and our novel multi-task and explainability algorithms can impact other research areas in machine learning, such as remote sensing and self-driving cars.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2021-STG

See all projects funded under this call

Host institution

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Net EU contribution
€ 1 494 810,00
Address
GEERT GROOTEPLEIN 10 ZUID
6525 GA Nijmegen
Netherlands
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 494 810,00

Beneficiaries (1)